Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
Drug repurposing is an efficient approach in new treatment development since it leverages previous work from one disease to another. While multiple sclerosis (MS), Parkinson's disease (PD), and Alzheimer's disease (AD) are all neurodegenerative diseases of the central nervous system (CNS)...
Main Authors: | Yuichiro Itoh, Rhonda R Voskuhl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5513529?pdf=render |
Similar Items
-
Sex differences in the neuronal transcriptome and synaptic mitochondrial function in the cerebral cortex of a multiple sclerosis model
by: Noriko Itoh, et al.
Published: (2023-11-01) -
Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions
by: Maarten E. Witte, et al.
Published: (2009-12-01) -
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
by: Federico Paolini Paoletti, et al.
Published: (2021-05-01) -
Sex differences in autoimmune diseases
by: Voskuhl Rhonda
Published: (2011-01-01) -
Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis
by: Rhonda Voskuhl, et al.
Published: (2022-08-01)